Bristol-Myers Squibb Co

BMY: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
rrVLOCK|m%tLOCK|jz&hT^Vf

Bristol-Myers Squibb Earnings: Revenue Growth From Newer Products as Pipeline Catalysts Near

Bristol reported 3% third-quarter revenue growth, and management raised revenue guidance for the full year to a range of $47.5 billion-$48.0 billion and narrowed its adjusted EPS guidance to $6.40-$6.60.

Sponsor Center